Sanofi, SNY is in the exchange NYSE and its industry is Drug Manufacturers – Major in the sector of Healthcare. Based in France, Sanofi, SNY has a market cap of 107606.6. Since its IPO date on the 7/1/2002, Sanofi, SNY performance year to date is 2.96%. Today Sanofi, SNY has gained -0.36%, with a current price of 41.99.
Ownership of the company is 16.40% for insider ownership while institutional ownership is 9.70%. The management of the company have seen the company have a payout ratio of *TBA. Return of assets are at *TBA, with return on investment at 6.50%.
In terms of debt levels and profit levels, Sanofi, SNY is seeing a long-term debt/equity of *TBA. While Total debt/equity is *TBA. With a profit margin of *TBA, this is combined with a gross margin of 68.80%, and operating margin of *TBA. Sanofi ability to meet debt levels, with a current ratio of *TBA, while the quick ratio is *TBA.
For the last year Sanofi, SNY has seen a EPS growth of 4.10%. A performance for the year of -17.98%. The 52-week high is -20.41%, and the 52-week low is 16.28%. The average volume for Sanofi, SNY is 925354.
With a target price of 52, can Sanofi, SNY reach this target? Looking at the value indicators of Sanofi, SNY. Sanofi has a P/E of 22.63 and a forward P/E of 13.31. Perhaps the more useful indicator than P/E, is PEG which has a value of 3.19. Sanofi also has a P/S and a P/B of 2.82 and 1.72 respectively. For P/cash, Sanofi has a value of *TBA, while it is *TBA for P/free cash flow.
At the current price of 41.99, Sanofi has a dividend yield of 3.94%. We see a return on equity of *TBA.
Looking more long-term Sanofi, is projected to get an EPS growth for the next five years of 7.10%. In the short-term an EPS growth of 0.16% in the next year is forecasted. This is after a EPS growth of 4.10% for this year and for the last five years a -4.40% growth has been seen.